• S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

  • 2021/02/27
  • 再生時間: 25 分
  • ポッドキャスト

S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Management

  • サマリー

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will focus on chronic kidney disease (CKD) in patients with or without diabetes and treatment with sodium-glucose cotransporter 2 (SGLT-2) inhibitors. The bottom line is, how should these treatments be incorporated into clinical practice?

    続きを読む 一部表示

あらすじ・解説

Visit http://morningcommutepodcast.com/SGLT2inhibitors3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will focus on chronic kidney disease (CKD) in patients with or without diabetes and treatment with sodium-glucose cotransporter 2 (SGLT-2) inhibitors. The bottom line is, how should these treatments be incorporated into clinical practice?

activate_samplebutton_t1

S1E3 - SGLT-2 Inhibitors Morning Commute: Optimizing Benefit in CKD Managementに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。